Nerve conduction assessment device

Information

  • Patent Grant
  • D1076100
  • Patent Number
    D1,076,100
  • Date Filed
    Thursday, February 3, 2022
    3 years ago
  • Date Issued
    Tuesday, May 20, 2025
    2 months ago
  • US Classifications
    Field of Search
    • US
    • D24 167
    • D24 168
    • D24 171
    • D24 186
    • D24 200
    • D24 211
    • D24 215
    • CPC
    • A61B5/4041
    • A61B5/24
    • A61B5/05
    • A61B2560/0468
    • A61B2560/0266
    • A61B2560/0425
  • International Classifications
    • 2402
    • Term of Grant
      15Years
Abstract
Description


FIG. 1 is a left perspective view of the top of the nerve conduction assessment device;



FIG. 2 is a top right perspective view thereof;



FIG. 3 is a bottom left perspective view thereof;



FIG. 4 is a bottom right perspective view thereof;



FIG. 5 is a top view thereof;



FIG. 6 is a bottom view thereof;



FIG. 7 is a right side elevational view thereof;



FIG. 8 is a left side elevational view thereof;



FIG. 9 is a front elevational view thereof; and,



FIG. 10 is a rear elevational view thereof.


Claims
  • The ornamental design for a nerve conduction assessment device, as shown and described.
US Referenced Citations (51)
Number Name Date Kind
2327874 Jong Aug 1943 A
D243417 Allen et al. Feb 1977 S
4033356 Hara Jul 1977 A
4121573 Crovella et al. Oct 1978 A
D255938 Hawke et al. Jul 1980 S
4419998 Heath Dec 1983 A
4603700 Nichols et al. Aug 1986 A
D299746 Guldalian, Jr. Feb 1989 S
5215100 Spitz et al. Jun 1993 A
5327902 Lemmen Jul 1994 A
5755750 Petruska et al. May 1998 A
5806522 Katims Sep 1998 A
5851191 Gozani Dec 1998 A
5991355 Dahlke Nov 1999 A
6132386 Gozani et al. Oct 2000 A
6146335 Gozani Nov 2000 A
D447806 Davey Sep 2001 S
6298255 Cordero et al. Oct 2001 B1
6312392 Herzon Nov 2001 B1
7459984 Wang et al. Dec 2008 B2
7760428 Sieckmann Jul 2010 B2
7844325 Takehara Nov 2010 B2
7917201 Gozani et al. Mar 2011 B2
D638131 Buckels et al. May 2011 S
8948876 Gozani et al. Feb 2015 B2
D737988 Tsai Sep 2015 S
9173581 Boettcher et al. Nov 2015 B2
10004445 Boettcher et al. Jun 2018 B2
D893730 Chun Aug 2020 S
10881311 Boettcher et al. Jan 2021 B2
20020173828 Gozani Nov 2002 A1
20030093006 Wells et al. May 2003 A1
20040231772 Leonard et al. Nov 2004 A1
20050083527 Flaherty et al. Apr 2005 A1
20060020291 Gozani et al. Jan 2006 A1
20060253167 Kurtz et al. Nov 2006 A1
20070129771 Kurtz et al. Jun 2007 A1
20070149892 Guldalian Jun 2007 A1
20070185409 Wu et al. Aug 2007 A1
20070219441 Carlin et al. Sep 2007 A1
20070279735 Sieckmann Dec 2007 A1
20080288026 Cross et al. Nov 2008 A1
20080306400 Takehara Dec 2008 A1
20080312551 Fadem Dec 2008 A1
20110087129 Chetham et al. Apr 2011 A1
20120016259 Odderson Jan 2012 A1
20120053436 Saueers et al. Mar 2012 A1
20120101358 Boettcher Apr 2012 A1
20120226186 Baars et al. Sep 2012 A1
20150038873 Boettcher Feb 2015 A1
20150174402 Thomas et al. Jun 2015 A1
Foreign Referenced Citations (12)
Number Date Country
118043 Nov 2007 CA
148280 Nov 2013 CA
1779456 May 2006 CN
306073092 Sep 2020 CN
307800483 Jan 2023 CN
60-41851 Mar 1985 JP
S60-194933 Oct 1985 JP
301045703.0000 Feb 2020 KR
WO 0009999 Feb 2000 WO
WO 2005040793 May 2005 WO
WO 2007047681 Apr 2007 WO
WO 2012037527 Mar 2012 WO
Non-Patent Literature Citations (42)
Entry
NC-stat DPNCheck neurometrix test, posted date unavailable [retrieved online May 22, 2024]. Retrieved from internet, https://www.medi-shop.gr/en/blood-analyzers/nc-stat-dpncheck-neurometrix-test (Year: 2024).
DPNCheck 2.0 by NeuroMetrix, posted date unavailable [retrieved online May 22, 2024]. Retrieved from internet, https://www.globenewswire.com/NewsRoom/AttachmentNg/aee7be42-c171-4ca3-90f7-e46344542209/en (Year: 2024).
Haltian and Mediracer, posted Feb. 22, 2017 [retrieved online May 22, 2024]. Retrieved from internet, https://www.businessoulu.com/en/for-media/news-archive/haltian-and-mediracer-have-started-co-operation-to-speed-up-mediracers-global-growth.html (Year: 2017).
NeuMed Nerve Conduction Study System for sale at Dr's Toy Store, posted date unavailable [retrieved online May 22, 2024]. Retrieved from internet, https://www.drstoystore.com/product/nerve-conduction-study-system-2/ (Year: 2024).
Albers et al., Subclinical Neuropathy Among Diabetes Control And Complications Trial Participants Without Diagnosable Neuropathy At Trial Completion, Diabetes Care, Oct. 2007, pp. 2613-2618.
Behse et al., Nerve Biopsy And Conduction Studies In Diabetic Neuropathy, Journal of Neurology, Neurosurgery, And Psychiatry, 1977, pp. 1072-1082.
Behse et al., Sensory Action Potentials And Biopsy Of The Sural Nerve In Neuropathy, Brain, 1978, pp. 473-493.
Benatar et al., Reference Data For Commonly Used Sensory And Motor Nerve Conduction Studies, Muscle & Nerve, Nov. 2009, pp. 772-794.
Boettcher, Bonniejean et al., A Rapid, Low-cost, Point-of-care Test for Diabetic Peripheral Neuropathy, Jun. 24, 2011.
Boulton et al., Diabetic Neuropathies, Diabetes Care, Apr. 2005, pp. 956-962.
Burke et al., Sensory Conduction Of The Sural Nerve In Polyneuropathy, Journal of Neurology, Neurosurgery, And Psychiatry, 1974, pp. 647-652.
Buschbacher, Sural And Saphenous 14-cm Antidromic Sensory Nerve Conduction Studies, America Journal of Physical Medicine & Rehabilitation, 2003, 82:421-426.
Charles et al., Low Peripheral Nerve Conduction Velocities And Amplitudes Are Strongly Related To Diabetic Microvascular Complications In Type 1 Diabetes, Diabetes Care, Dec. 2010, pp. 2648-2653.
Dros et al., Accuracy of Monofilament Testing to Diagnose Peripherai Neuropathy: A Systematic Review, Annals Of Family Medicine, Nov./Dec. 2009, pp. 555-558.
Dyck et al., Clinical And Neuropathological Criteria For The Diagnosis And Staging Of Diabetic Polyneuropathy, Brain, 1985, pp. 861-880.
Dyck et al., Fiber Loss Is Primary And Multifocal In Sural Nerves In Diabetic Polyneuropathy, Annals of Neurology, May 1986, pp. 425-439.
Dyck et al., Signs And Symptoms Versus Nerve Conduction Studies To Diagnose Diabetic Sensorimotor Polyneuropathy: CI Vs. Nphys Trial, Muscle & Nerve, Aug. 2010, pp. 157-164.
England et al., Distal Symmetrical Polyneuropathy: A Definition For Clinical Research, Neurology, Jan. 2005, pp. 199-207.
Esper et al., Sural and Radial Sensory Responses In Healthy Adults: Diagnostic Implications For Polyneuropathy, Muscle & Nerve, May 2005, pp. 628-632.
Gibbons et al., Diabetic Neuropathy, A Cross-Sectional Study Of The Relationship Among Tests Of Neurophysiology, Diabetes Care, Dec. 2010, pp. 2629-2634.
Gordois et al., The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S., Diabetes Care, Jun. 2003, pp. 1790-1795.
Harrison et al., The Neuropathic Factor In The Aetiology Of Diabetic Foot Ulcers, Journal Of The Neurological Science, 1976, pp. 217-223.
Herman et al., Underdiagnosis Of Peripheral Neuropathy In Type 2 Diabetes, Diabetes Care, Jun. 2005, pp. 1480-1481.
Kihara et al., Comparison of Electrophysiologic And Autonomic Tests In Sensory Diabetic Neuropathy, Clinical Autonomic Research, Aug. 1998, pp. 213-220.
Kirkman et al., Impact Of A Program To Improve Adherence To Diabetes Guidelines By Primary Care Physicians, Diabetes Care, Nov. 2002, pp. 1946-1951.
Kiziltan et al., Peripheral Neuropathy In Patients With Diabetic Foot Ulcers: Clinical And Nerve Conduction Study, Journal Of The Neurological Sciences, 2007, pp. 75-79.
Kong et al., Utilization Of Nerve Conduction Studies For The Diagnosis ot Polyneuropathy In Patients With Diabetes: A Retrospective Analysi s Of A Large Patient Series, Journal of Diabetes Science and Technology, Mar. 2008, pp. 268-274.
Kong, Xuan et al., Repeatability of nerve conduction measurements derived entirely by computer methods, BioMedical Engineering Online, 2009, 8:33.
National Diabetes Fact Sheet, Department Of Health And Human Services, Centers for Disease Control And Prevention, 2007.
Pambianco et al., Risk Factor Associations With Clinical Distal Symmetrical Polyneuropathy And Various Neuropalhy Screening Instruments And Protocols in Type 1 Diabetes, Diabetes Research And Clinical Practice, 2011, pp. e15-e20.
Pambianco et al., Ttle Assessment Of Clinical Distal Symmetric Polyrieuropathy in Type 1 Diabetes: A Comparison of Methodologies From The Pittsburch Epidemiology of Diabetes Complications Cohort, Diabetes Research And Clinical Practice, 2011. pp. 280-287.
Perkins et al., Glycemic Control Is Related To The Morphological Severity Of Diabetic Sensorimotor Polyneuropathy, Diabetes Care, Apr. 2001, pp. 748-752.
Perkins et al., Multi-Site Testing With A Point-Of-Care Nerve Conduction Device Can Be Used In An Algorithm To Diagnose Diabeitic Sensorimotor Polyneuropathy, Diabetes Care, Mar. 2008, pp. 522-524.
Perkins et al., Validation of a Novel Point-of-Care Nerve Conduction Device for the Detection of Diabetic Sensorimotor Polyneuropathy, Diabetes Care, Sep. 2006, pp. 2023-2027.
Russell et al., Sural Nerve Myelinated Fiber Density Differences Associated With Meaningful Changes In Clinical And Electrophysiologic Measurement, Journal Of The Neurological Sciences, 1996, pp. 114-117.
Standards Of Medical Care In Diabetes—2006, Diabetes Care, Jan. 2006, pp. S4-S42.
Stetson et al., Effects Of Age, Sex, And Anthropometric Factors On Nerve Conduction Measures, Muscle & Nerve, Oct. 1992, pp. 1095-1104.
Trojaborg et al., Sural Nerve Condudion Parameters in Normal Subjects Related To Age, Gender, Temperature, And Height: A Reappraisal, Muscle & Nenm, Jun. 1992, pp. 666-671.
Veves et al., The Relationship Between Sural Nerve Morphometric Findings And Measures Of Peripheral Nerve Function In Mild Diabetic Neuropathy, Diabetic Medicine, 1991, pp. 917-921.
Vinik et al . . . , Sural Sensory Action Potential Identifies Diabetic Peripheral Neuropathy Responders To Therapy, Muscle & Nerve, Nov. 2005, pp. 619-625.
Vrancken et al., The Realistic Yield Of Lower Leg SNAP Amplitudes And SRAR in The Routine Evaluation Of Chronic Axonal Polyneuropathies, J Neurol, 2008, pp. 1127-1135.
Wald et al., On A Test Whether Two Samples Are From The Same Population, The Annals of Mathematical Statistics, 1940, pp. 147-162.